India’s equity market surged sharply on the first day of the December derivatives series with the benchmark indices - BSE Sensex and NSE Nifty - advancing more than 1.20 percent each. The sharp ...

Futures for the Dow Jones Industrial Average and other major stock indexes fell sharply in premarket trading Monday, as Wall Street threatened to give up some of last week's stock market rally. Among ...

Wondering if eating bread affects your weight? Here’s what research shows about how types, portions, and overall diet play a role. Bread has long been a dietary staple, but it’s often blamed for ...

Weight gain during your period is temporary and usually ends once the period is over. Eating complex carbohydrates and reducing salt may help lessen weight gain during periods. Severe PMS symptoms may ...

A redesigned Weight Watchers experience pairs comprehensive GLP-1 support with personalised nutrition, coaching, community support, and cutting-edge technology to help members meet their weight loss ...

If you are wondering whether Nu Holdings is still worth buying after its massive run, you are not alone. This article is ...

New England held an open spot on the practice squad after veteran running back D’Ernest Johnson, a three-time standard ...

Jillian Kubala, MS, is a registered dietitian based in Westhampton, NY. Jillian uses a unique and personalized approach to help her clients achieve optimal wellness through nutrition and lifestyle ...

Gain Therapeutics’s (NASDAQ:GANX) is one of the 12 hot penny stocks to invest in right now. At the Society for Neuroscience annual meeting in San Diego on November 20, Gain Therapeutics, Inc.

Weight loss jabs could be used to treat Alzheimer’s disease after a study found the drug may slow cognitive decline. Liraglutide, sold under the brand name Saxenda, is prescribed to control blood ...

For those willing to take a chance, let's consider two biotech stocks that could eventually become solid, well-established drugmakers: CRISPR Therapeutics ( CRSP 0.76%) and Viking Therapeutics ( VKTX ...

Novo Nordisk announced Monday that in two closely watched studies, an oral version of semaglutide — the active ingredient in weight loss drugs — failed to help slow the progression of Alzheimer’s. The ...